Per Briand
Impact in
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
- Oncology top 5%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
-
- Genomics and Chromatin Dynamics 6
- Genetics 27
- Estrogen and related hormone effects 21
- Animal Genetics and Reproduction 5
- Co-authors
- Anne E. Lykkesfeldt (18 shared papers)Ole W. Petersen (8 shared papers)Bo van Deurs (5 shared papers)Mogens Winkel Madsen (10 shared papers)Shoukat Dedhar (1 shared paper)Mina J. Bissell (1 shared paper)Fei Wang (1 shared paper)Carolyn A. Larabell (1 shared paper)
- Journals
- International Journal of Cancer (6 papers)Molecular and Cellular Endocrinology (4 papers)British Journal of Cancer (3 papers)Proceedings of the National Academy of Sciences (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- DenmarkFranceUnited States
In The Last Decade
Per Briand
56 papers receiving 1.9k citations
Per Briand's Hit Papers
Peers
Comparison fields: 5 of 91
- Immunology and Allergy 277
- Oncology 894
- Cancer Research 372
- Cell Biology 352
- Genetics 535
Countries citing papers authored by Per Briand
This map shows the geographic impact of Per Briand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Briand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Briand more than expected).
Fields of papers citing papers by Per Briand
This network shows the impact of papers produced by Per Briand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Briand. The network helps show where Per Briand may publish in the future.
Co-authors
The 25 scholars most cited alongside Per Briand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology Hit paper breakdown → | 1998 | 535 |
| 2 | The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. | 1975 | 201 |
| 3 | 1987 | 200 | |
| 4 | Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. | 1996 | 101 |
| 5 | Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration. | 1984 | 86 |
| 6 | 1986 | 78 | |
| 7 | 1995 | 72 | |
| 8 | Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements. | 1992 | 47 |
| 9 | 2001 | 46 | |
| 10 | 1984 | 40 | |
| 11 | 1994 | 39 | |
| 12 | 1994 | 34 | |
| 13 | 2000 | 32 | |
| 14 | Differential tumorigenicity of two autologous human breast carcinoma cell lines, HMT-3909S1 and HMT-3909S8, established in serum-free medium. | 1990 | 32 |
| 15 | 1994 | 28 | |
| 16 | 1967 | 27 | |
| 17 | The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1. | 1998 | 26 |
| 18 | 1976 | 25 | |
| 19 | 1989 | 24 | |
| 20 | 2001 | 23 |
About Per Briand
Per Briand is a scholar working on Molecular Biology, Genetics, Oncology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 57 papers that have together received 2.0k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (21 papers), Cancer Cells and Metastasis (13 papers), HER2/EGFR in Cancer Research (7 papers), Genomics and Chromatin Dynamics (6 papers), Animal Genetics and Reproduction (5 papers), Cancer Genomics and Diagnostics (4 papers), Effects and risks of endocrine disrupting chemicals (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Immunology and Allergy (277 citations), Oncology (894 citations), Cancer Research (372 citations), Cell Biology (352 citations) and Genetics (535 citations). Per Briand has collaborated with scholars based in Denmark, France and United States. Frequent co-authors include Anne E. Lykkesfeldt, Ole W. Petersen, Bo van Deurs, Mogens Winkel Madsen, Shoukat Dedhar, Mina J. Bissell, Fei Wang, Carolyn A. Larabell, N. R. Hartmann and Piotr Janik. Their work appears in journals such as International Journal of Cancer, Molecular and Cellular Endocrinology, British Journal of Cancer, Proceedings of the National Academy of Sciences and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.